Alentis Therapeutics

Alentis Therapeutics

Alentis Therapeutics

Alentis Therapeutics discovers and develops novel medications to treat advanced liver diseases.
Raised
$12.7M
Follow us
Latest funding
$12,681,250
Venture capital (Series A) - 2019
BioMedPartners Pureos Bioventures
Team Size
1–10
Employees

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when Alentis Therapeutics makes some noise.